Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
ConditionPulmonary Fibrosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Pittsburgh
About this trial
The purposes of this study are:
* to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years of age or older
Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans.
Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease.
Disqualifiers
Under 18 years of age
Non-fibrotic ILD
Trial population
Patient population includes patients who have been diagnosed with a fibrotic interstitial lung disease who have been seen by a Simmons Center Physician.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Blood samples will be collected to validate in a large cohort the per- allele associations of prespecified SNPs with IPF case status adjusted for age , sex. smoking, and principal components of ancestry.
Time frame
Sample collection will occur up to 5 years based on the current rate of sample collection.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov